全文获取类型
收费全文 | 19122篇 |
免费 | 1315篇 |
国内免费 | 452篇 |
专业分类
耳鼻咽喉 | 222篇 |
儿科学 | 599篇 |
妇产科学 | 329篇 |
基础医学 | 2378篇 |
口腔科学 | 413篇 |
临床医学 | 1839篇 |
内科学 | 4513篇 |
皮肤病学 | 360篇 |
神经病学 | 1199篇 |
特种医学 | 538篇 |
外国民族医学 | 2篇 |
外科学 | 2042篇 |
综合类 | 1146篇 |
一般理论 | 4篇 |
预防医学 | 1463篇 |
眼科学 | 603篇 |
药学 | 1362篇 |
7篇 | |
中国医学 | 399篇 |
肿瘤学 | 1471篇 |
出版年
2024年 | 30篇 |
2023年 | 190篇 |
2022年 | 340篇 |
2021年 | 641篇 |
2020年 | 397篇 |
2019年 | 537篇 |
2018年 | 695篇 |
2017年 | 498篇 |
2016年 | 482篇 |
2015年 | 634篇 |
2014年 | 772篇 |
2013年 | 959篇 |
2012年 | 1453篇 |
2011年 | 1499篇 |
2010年 | 896篇 |
2009年 | 640篇 |
2008年 | 1066篇 |
2007年 | 1140篇 |
2006年 | 988篇 |
2005年 | 1050篇 |
2004年 | 948篇 |
2003年 | 906篇 |
2002年 | 813篇 |
2001年 | 483篇 |
2000年 | 509篇 |
1999年 | 422篇 |
1998年 | 152篇 |
1997年 | 124篇 |
1996年 | 140篇 |
1995年 | 106篇 |
1994年 | 81篇 |
1993年 | 67篇 |
1992年 | 156篇 |
1991年 | 133篇 |
1990年 | 113篇 |
1989年 | 114篇 |
1988年 | 102篇 |
1987年 | 87篇 |
1986年 | 76篇 |
1985年 | 65篇 |
1984年 | 53篇 |
1983年 | 33篇 |
1982年 | 21篇 |
1981年 | 24篇 |
1980年 | 24篇 |
1979年 | 17篇 |
1978年 | 14篇 |
1977年 | 19篇 |
1976年 | 18篇 |
1975年 | 16篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Maria Gonzalez-Cao Cristina Carrera Juan Francisco Rodriguez Moreno Pedro Rodríguez-Jiménez Mónica Antoñanzas Basa Rosa Feltes Ochoa Teresa Puertolas Eva Muñoz-Couselo José Luis Manzano Ivan Marquez-Rodas Juan Martín-Liberal Ainara Soria Pilar Lopez Criado Almudena Garcia-Castaño Aram Boada Pablo Ayala de Miguel Susana Puig Guillermo Crespo Alfonso Berrocal 《Journal of the American Academy of Dermatology》2021,84(5):1412-1415
5.
6.
Luis Veloza Cristina Teixido Natalia Castrejon Fina Climent Ana Carri Marta Marginet Davide Soldini Blanca Gonzlez‐Farr Inmaculada Ribera‐Cortada Armando Lopez‐Guillermo Eva Gonzlez‐Barca Adriana Sierra Mileyka Herrera Cndida Gmez Adriana Garcia Olga Balagu Elias Campo Antonio Martinez 《Histopathology》2019,75(6):799-812
7.
Hagop Kantarjian Tapan Kadia Courtney DiNardo Naval Daver Gautam Borthakur Elias Jabbour Guillermo Garcia-Manero Marina Konopleva Farhad Ravandi 《Blood cancer journal》2021,11(2)
Progress in the understanding of the biology and therapy of acute myeloid leukemia (AML) is occurring rapidly. Since 2017, nine agents have been approved for various indications in AML. These included several targeted therapies like venetoclax, FLT3 inhibitors, IDH inhibitors, and others. The management of AML is complicated, highlighting the need for expertise in order to deliver optimal therapy and achieve optimal outcomes. The multiple subentities in AML require very different therapies. In this review, we summarize the important pathophysiologies driving AML, review current therapies in standard practice, and address present and future research directions.Subject terms: Prognosis, Health services 相似文献
8.
9.
Ana M. Gómez Angelica Imitola Diana Henao Maira García-Jaramillo Marga Giménez Clara Viñals Bruno Grassi Mariana Torres Isabella Zuluaga Oscar Mauricio Muñoz Martin Rondón Fabián León-Vargas Ignacio Conget 《Diabetes & Metabolic Syndrome: Clinical Research & Reviews》2021,15(1):267-272
Background and aimsDespite using sensor-augmented pump therapy (SAPT) with predictive low-glucose management (PLGM), hypoglycemia is still an issue in patients with type 1 Diabetes (T1D). Our aim was to determine factors associated with clinically significant hypoglycemia (<54 mg/dl) in persons with T1D treated with PLGM-SAPT.Methodology: This is a multicentric prospective real-life study performed in Colombia, Chile and Spain. Patients with T1D treated with PLGM-SAPT, using sensor ≥70% of time, were included. Data regarding pump and sensor use patterns and carbohydrate intake from 28 consecutive days were collected. A bivariate and multivariate Poisson regression analysis was carried out, to evaluate the association between the number of events of <54 mg/dl with the clinical variables and patterns of sensor and pump use.Results188 subjects were included (41 ± 13.8 years-old, 23 ± 12 years disease duration, A1c 7.2% ± 0.9). The median of events <54 mg/dl was four events/patient/month (IQR 1–10), 77% of these events occurred during day time. Multivariate analysis showed that the number of events of hypoglycemia were higher in patients with previous severe hypoglycemia (IRR1.38; 95% CI 1.19–1.61; p < 0.001), high glycemic variability defined as Coefficient of Variation (CV%) > 36% (IRR 2.09; 95%CI 1.79–2.45; p < 0.001) and hypoglycemia unawareness. A protector effect was identified for adequate sensor calibration (IRR 0.77; 95%CI 0.66–0.90; p:0.001), and the use of bolus wizard >60% (IRR 0.74; 95%CI 0.58–0.95; p:0.017).ConclusionIn spite of using advanced SAPT, clinically significant hypoglycemia is still a non-negligible risk. Only the identification and intervention of modifiable factors could help to prevent and reduce hypoglycemia in clinical practice. 相似文献
10.
José A. Lorente Pablo Cardinal-Fernández Diego Muñoz Fernando Frutos-Vivar Arnaud W. Thille Carlos Jaramillo Aida Ballén-Barragán José M. Rodríguez Oscar Peñuelas Guillermo Ortiz José Blanco Bruno Valle Pinheiro Nicolás Nin María del Carmen Marin Andrés Esteban Taylor B. Thompson 《Intensive care medicine》2015,41(11):1921-1930